Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 2"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Standard+of+Care%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22
/vufind/Search/Results?lookfor=%22Standard+of+Care%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22
Search /vufind/Search2/Results?lookfor=%22Standard+of+Care%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22
PubPharm (73)
1
Adipose tissu derived-stem cells injections from patients with sclerodermia to treat thier refractory digital ulcers. : Subcutaneous injections of autologous cultured adipose-derived stroma/stem cells to heal refractory ischemic digital ulcers in patients with scleroderma : a phase II study - ADUSE
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Adipose tissu derived-stem cells injections from patients with sclerodermia to treat thier refractory digital ulcers. : Subcutaneous injections of autologous cultured adipose-derived stroma/stem cells to heal refractory ischemic digital ulcers in patients with scleroderma : a phase II study - ADUSE
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
A Phase 2 study for the Combination of VB10.16 and Atezolizumab in Patients with Advanced Cervical Cancer : A Multi-Centre, Open-label Phase 2a Trial of the Combination of VB10.16 and Atezolizumab in Patients with Advanced or Recurrent, Non-resectable HPV16-Positive Cervical Cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
A Phase 2 study for the Combination of VB10.16 and Atezolizumab in Patients with Advanced Cervical Cancer : A Multi-Centre, Open-label Phase 2a Trial of the Combination of VB10.16 and Atezolizumab in Patients with Advanced or Recurrent, Non-resectable HPV16-Positive Cervical Cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
A Phase 2 study for the Combination of VB10.16 and Atezolizumab in Patients with Advanced Cervical Cancer : A Multi-Centre, Open-label Phase 2a Trial of the Combination of VB10.16 and Atezolizumab in Patients with Advanced or Recurrent, Non-resectable HPV16-Positive Cervical Cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
A Phase 2 study for the Combination of VB10.16 and Atezolizumab in Patients with Advanced Cervical Cancer : A Multi-Centre, Open-label Phase 2a Trial of the Combination of VB10.16 and Atezolizumab in Patients with Advanced or Recurrent, Non-resectable HPV16-Positive Cervical Cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1 3 Alterations (FIGHT-209) : A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1 3 Alterations (FIGHT-209)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
8
A Phase 2 study for the Combination of VB10.16 and Atezolizumab in Patients with Advanced Cervical Cancer : A Multi-Centre, Open-label Phase 2a Trial of the Combination of VB10.16 and Atezolizumab in Patients with Advanced or Recurrent, Non-resectable HPV16-Positive Cervical Cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
9
A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1 3 Alterations (FIGHT-209) : A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1 3 Alterations (FIGHT-209)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
10
A Phase 2 study for the Combination of VB10.16 and Atezolizumab in Patients with Advanced Cervical Cancer : A Multi-Centre, Open-label Phase 2a Trial of the Combination of VB10.16 and Atezolizumab in Patients with Advanced or Recurrent, Non-resectable HPV16-Positive Cervical Cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
1
2
3
4
5
6
7
8
Nächster »
[8]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Phase: Phase 2
Medienart
73
Aufsätze
73
E-Artikel
73
E-Ressourcen
Zeitschriftentitel
72
WHO International Clinical Trials Registry Plat...
1
ClinicalTrials.gov
Thema
73
610
Phase: Phase 2
73
Study Type: Interventional
40
Recruitment Status: Not yet recruiting
32
Recruitment Status: Authorised-recruitment may ...
10
Medical Condition: Advanced or recurrent non-re...
8
Medical Condition: HER2 negative hormone recept...
8
Medical Condition: HER2 negative hormone recept...
8
Medical Condition: Subjects with a Urea Cycle D...
4
Medical Condition: HER2 negative hormone recept...
4
Medical Condition: Male and female participants...
2
Medical Condition: HER2 negative hormone recept...
2
Medical Condition: HER2 negative hormone recept...
2
Medical Condition: HER2 negative hormone recept...
2
Medical Condition: Newly diagnosed Glioblastoma...
2
Medical Condition: Patients a least 18 years of...
2
Medical Condition: Patients with platinum-resis...
2
Medical Condition: Patients with platinum-resis...
2
Medical Condition: Patients with platinum-resis...
2
Medical Condition: Patients with platinum-resis...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
55
2020-
18
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
73
Englisch
Haven't found what you're looking for?
Wird geladen...